Craven House Capital PLC On-line Platform Launched by Investee, Rosedog Ltd
March 23 2020 - 7:19AM
RNS Non-Regulatory
TIDMCRV
Craven House Capital PLC
23 March 2020
Craven House Capital plc
("Craven House" or the "Company")
On-line Retail and Wholesale Platforms Launched by Craven House
Investee, Rosedog Limited
The Company is pleased to inform shareholders and the market
that Rosedog Limited ("Rosedog"), a private company in which Craven
House announced on 13(th) March 2020 it had acquired a 29.9%
interest, has launched two on-line sales platforms to promote and
execute sales of its health supplements:
-- www.provitos.com - a B-2-C platform for the promotion, sale
and fulfilment of proprietary diet supplements, including popular
vitamin supplements and Omega 3 derived from fish oils, targeted at
consumers and delivered to purchasers' homes. The products will
consist primarily of diet supplements that have been developed and
produced over the past 23 years by Vital Pharma AS in the Norwegian
city of Trondheim. Products supplied through the platform will be
branded " Pro -Vitos ";
-- www.biovitos.com - a B-2-B platform offering a similar range
of products as described above but branded as " Bio Vitos ",
targeting traditional, European pharmacies and health-food
retailers.
The marketing and sales effort will be directed across Europe,
with an initial focus on the opportunities in Sweden, Denmark and
Germany. Pro-Vitos ' and Bio Vitos ' websites presently carry
Swedish-, Danish-, German- and English-language product and other
information.
Mark Pajak, non-executive director of Craven House, stated, "We
are gratified to see one of our most recent, simultaneous
e-business investments making immediate progress in executing its
sales and marketing strategy. We look forward, as and when this
becomes appropriate, to announcing further developments with
Rosedog and the Company's four other recent investments in the
e-commerce arena."
Ends
For further information please contact:
Craven House Capital Plc Tel: 0203 286 8130
Mark Pajak
www.Cravenhousecapital.com
SI Capital Tel: 01483 413500
Broker
Nick Emerson
www.sicapital.co.uk
Keith, Bayley, Rogers & Co. Limited Tel: 020 7464 4091 / 07506
Financial Adviser to the Investee 434107
(in relation only to its client, Tel: 020 7464 4098
Rosedog Limited)
Graham Atthill-Beck
Graham.Atthill-Beck@kbrl.co.uk
Brinsley Holman
Brinsley.Holman@kbrl.co.uk
RNS Reach is an investor communication service aimed at
assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases such as
marketing messages, corporate and product information into the
public domain. An RNS Regulatory announcement is required to be
notified under the AIM Rules for Companies.
About Craven House Capital:
The Company's Investing Policy is to invest in or acquire a
portfolio of companies, partnerships, joint ventures, businesses or
other assets globally in any geographic jurisdiction. The company
will invest in both developed and developing markets providing long
term patient capital and is often involved in special situations,
restructuring, expansion and turn around investments in crisis and
transitioning economies.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAJJMTTMTBTBAM
(END) Dow Jones Newswires
March 23, 2020 08:19 ET (12:19 GMT)
Craven House Capital (LSE:CRV)
Historical Stock Chart
From Apr 2024 to May 2024
Craven House Capital (LSE:CRV)
Historical Stock Chart
From May 2023 to May 2024